ClinConnect ClinConnect Logo
Search / Trial NCT04950985

Improving Outcomes of Necrotising Otitis Externa

Launched by UNIVERSITY OF OXFORD · Jun 25, 2021

Trial Information

Current as of April 26, 2025

Active, not recruiting

Keywords

Infection Antimicrobials Otitis Externa

ClinConnect Summary

This clinical trial is focused on understanding a condition called Necrotising Otitis Externa (NOE), which is a serious ear infection that can cause significant problems if not treated properly. The study is taking place at multiple locations in the UK and is currently active but not enrolling new participants. Researchers are looking at adult patients who are 18 years and older and have a clinical diagnosis of possible NOE, especially if they have had or will have a CT scan (a type of imaging test) as part of their regular medical care.

To participate in this trial, individuals must not have had a previous diagnosis of NOE and should be receiving their CT scan at one of the study sites. Participants can expect to be part of a thorough observation process that helps doctors understand and improve the treatment of this condition. This study aims to gather valuable information to enhance patient outcomes and care for those affected by NOE.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (≥ 18 years old).
  • Clinical diagnosis of possible NOE for whom CT imaging is requested or has been done as part of routine clinical care.
  • Exclusion Criteria:
  • Any previous clinical diagnosis of NOE.
  • CT performed or due to be performed at hospital other than recruiting study site.

About University Of Oxford

The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.

Locations

Oxford, Oxfordshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Susanne Hodgson, PhD

Principal Investigator

University of Oxford

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials